Endocrine Fellows Series: Type 1 Diabetes Care and Management

Event Information

Meeting Type: Physical
Meeting Website: https://www.endocrine.org/T1Dfellows
Dates: March 24 - 26, 2020
Location: San Francisco, CA , United States
Intended Audience: , Early Career
Purpose: Education, Scientific
Number of CME Credits Offered: 21

Topics: Diabetes Mellitus and Glucose Metabolism, General Endocrine Practice, Pediatric Endocrine Practice

Description:

Endocrine Fellows Series: Type 1 Diabetes Care and Management is a comprehensive conference for adult and pediatric endocrine fellows interested in type 1 diabetes (T1D). The unique and highly-sought after program is an opportunity learn from leaders in the field through interactive sessions, small group discussions, and hands-on learning. The curriculum provides comprehensive education not typically taught in fellowship and opportunities to connect with thought-leaders and peers.

Join Now

The conference will be held March 24–26, 2020 as a preconference event to the Endocrine Society's Annual Meeting & Expo (ENDO) to be held March 28–31, 2020 in San Francisco, California. Fellows accepted to the program receive a travel stipend and housing to attend the fellows’ conference held March 24–26. Watch a short video from our faculty and past fellows to learn about the value of the program.

All fellows must apply to be considered.

Key Dates and Information:

  • Open to all adult and pediatric endocrine fellows worldwide
  • Travel stipend and housing for the conference is included
  • Call for applications – August 26 – November 7, 2019
  • Award notices sent November 22, 2019
  • Opening evening reception and keynote – March 24, 2020
  • Comprehensive conference – March 24 – 26, 2020

Application Period: August 27 – November 7, 2019

Adult and pediatric endocrine fellows worldwide that are interested in improving T1D care and management are encouraged to apply.

Join Now

Accepted fellows:

  • Receive a travel stipend and housing to attend the conference from March 24–26, 2020
  • Meet and learn from thought-leaders on topics that include T1D diagnosis, hypoglycemia prevention, insulin therapy, sick day management, exercise, diabetes technology, and patient communication
  • Participate in a comprehensive curriculum specially designed to support early career endocrinologists through engaging discussions and opportunities to connect with thought-leaders and peers
  • Have the opportunity to extend stay to attend ENDO 2020 from March 28–31 (note that registration to ENDO 2020 is not included with the fellows' conference)  

Eligibility Criteria:

The conference is open to all endocrine fellows with an interest in improving T1D care and management. Current full or part-time faculty members are ineligible. Past conference attendees are ineligible. Endocrine Society membership is not required; however, preference may be given to current members. Check your membership prior to submission.

At the time of submission, applicants must have:

  • Obtained an MD or DO degree, or equivalent
  • Be actively enrolled as a 1st, 2nd, or 3rd year fellow in an accredited fellowship training program in adult or pediatric endocrinology.

Application Process:

Call for applications opens on Monday, August 26, 2019. Deadline for the online application is 11:59 PM pacific standard time on November 7, 2019. All applicants must complete/submit the following:

  • Complete the online application form
     
  • Submit a letter of recommendation from the applicant’s Program Director
     
  • Submit a personal statement of interest of 2000 characters or less (approximately 300 words or less) that highlights 1) your interests in and/or relationship to T1D and 2) how you believe the conference will impact your career in endocrinology
     
  • Optional submission of a challenge clinical case question of 3000 characters or less (approximately 500 words or less) relating to T1D. Cases from accepted fellows are provided to faculty in advance of the conference.
     
  • A Federal regulation called the Physician Payments Sunshine Act requires certain transfers of value to physicians be reported to the Center for Medicare and Medicaid Services (CMS). Therefore, the Endocrine Society now requires all participants to provide both their National Provider Identifier (NPI) number and state license number when applicable.

Program Directors:

Irl Hirsch
Irl B. Hirsch, MD
Professor of Medicine
University of Washington School of Medicine

Davida F. Kruger
Davida F. Kruger, MSN, APN-BC, BC-ADM
Certified Nurse Practitioner
Henry Ford Health System

Ana Ramirez Berlioz
Ana Ramirez Berlioz, MD
Endocrine Fellow
University of Missouri-Columbia


Event Contact

Email: info@endocrine.org
Phone: 202.736.9704 or 1.888.363.6274